O
RIGL icon

OppenheimerFunds’s Rigel Pharmaceuticals RIGL Stock Holding History

OppenheimerFunds’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$12.8M Hold
500,000
– – 0.02% 636
2018
Q4 		$11.5M Hold
500,000
– – 0.02% 642
2018
Q3 		$16.1M Hold
500,000
– – 0.02% 640
2018
Q2 		$14.2M Sell
500,000
-1,368
-0.3% -$48.7K 0.02% 662
2018
Q1 		$17.7M Buy
501,368
+352
+0.1% +$14.1K 0.02% 595
2017
Q4 		$19.4M Buy
501,016
+808
+0.2% +$30.8K 0.02% 595
2017
Q3 		$12.7M Sell
500,208
-80
-0% -$1.95K 0.02% 704
2017
Q2 		$13.7M Buy
500,288
+131
+0% +$3.58K 0.02% 679
2017
Q1 		$16.6M Buy
500,157
+157
+0% +$4K 0.02% 636
2016
Q4 		$11.9M Hold
500,000
– – 0.02% 721
2016
Q3 		$18.4M Hold
500,000
– – 0.02% 598
2016
Q2 		$11.2M Hold
500,000
– – 0.01% 709
2016
Q1 		$10.4M Hold
500,000
– – 0.01% 718
2015
Q4 		$15.2M Hold
500,000
– – 0.02% 649
2015
Q3 		$12.3M Hold
500,000
– – 0.02% 675
2015
Q2 		$16.1M Hold
500,000
– – 0.02% 639
2015
Q1 		$17.9M Hold
500,000
– – 0.02% 620
2014
Q4 		$11.3M Hold
500,000
– – 0.01% 736
2014
Q3 		$9.7M Hold
500,000
– – 0.01% 745
2014
Q2 		$18.1M Hold
500,000
– – 0.02% 601
2014
Q1 		$19.4M Hold
500,000
– – 0.02% 578
2013
Q4 		$14.3M Sell
500,000
-700,000
-58% -$20.5M 0.02% 655
2013
Q3 		$43M Buy
1,200,000
+600,000
+100% +$21.9M 0.03% 514
2013
Q2 		$20M Buy
+600,000
New +$27.2M 0.03% 510

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

OppenheimerFunds's RIGL Position: Q1 2019 in Review

OppenheimerFunds held its Rigel Pharmaceuticals (RIGL) position steady in Q1 2019 at 500,000 shares worth $12.8M. The position accounts for 0.02% of the portfolio, ranked #636.

OppenheimerFunds first reported a position in RIGL in Q2 2013 and has held it in 24 quarters since. The position peaked at $43M in Q3 2013. 131 funds tracked by Wall St. Rank hold RIGL as of Q1 2019.

  • OppenheimerFunds held 500,000 shares of Rigel Pharmaceuticals worth $12.8M as of Q1 2019.
  • OppenheimerFunds left its Rigel Pharmaceuticals share count unchanged in Q1 2019.
  • Rigel Pharmaceuticals made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #636 holding.
  • OppenheimerFunds first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Rigel Pharmaceuticals position peaked at $43M in Q3 2013.
  • 131 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.